Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease

Study Identifier
P15-720
CT.gov Identifier
NCT02906488
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Parkinson's Disease
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    18 - 99 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    1\. Patients with Parkinson's disease using Duodopa for the purpose of improving circadian change (wearing-off phenomenon) of symptoms of Parkinson's disease in which sufficient effect cannot be obtained with existing drug therapy including levodopa-containing drugs.
    Exclusion Criteria:
    NA

    Protocol Summary

    The purpose of this study is to assess the safety and efficacy of long-term use of Duodopa in patients with Parkinkon's disease in actual usage

    Study Locations

    Location
    Status
    Location
    Nagoya University Hospital /ID# 212303
    Nagoya, Aichi-ken, Japan, 466-8560
    Status
    Not applicable
    Location
    Nagoya City University Hospital /ID# 166893
    Nagoya, Aichi-ken, Japan, 467-8602
    Status
    Not applicable
    Location
    Toyota Memorial Hospital /ID# 166891
    Toyota-shi, Aichi-ken, Japan, 471-8513
    Status
    Not applicable
    Location
    Akita City Hospital /ID# 207121
    Akita, Akita, Japan, 010-0933
    Status
    Not applicable
    Location
    National Hospital Organization Akita National Hospital /ID# 207374
    Yurihonjo-shi, Akita, Japan, 018-1301
    Status
    Not applicable
    Location
    Aomori Prefectural Central Hospital /ID# 165286
    Aomori, Aomori, Japan, 030-8553
    Status
    Not applicable
    Showing {first} - {last} of {total} Results